Study S002559

A Phase 2 Study of Once-Daily RGT001-075 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities (COMO-1)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06867718
Acronym: COMO-1
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: DOUBLE
Status: COMPLETED
Enrollment: 267
Start: 2025-01-24
Primary completion: 2025-11-06
Lead sponsor: Regor Pharmaceuticals Inc.
Conditions: Obesity or Overweight
Interventions: DRUG:RGT001-075; DRUG:Placebo Comparator
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Percent change from baseline in body weight at Week 36 [Baseline and 36 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.